|
Forum MaterialsPolicy Brief: Reducing Health Disparities: Using Health Risk Assessments to Improve Viral Hepatitis Screening and Immunization Overview of Hepatitis in California: Health and Economic Burdens Time is Now To Reverse Hepatitis Trend, Experts Say, David Gorn, California Healthline
National ResourcesCalifornia ResourcesUseful Links
|
Viral Hepatitis: Disparities and OpportunitiesWhen: Where: Viral hepatitis is often referred to as a silent epidemic. The vast majority of individuals infected with hepatitis B virus (HBV) or hepatitis C virus (HCV) do not know they are infected, that they can infect others, and that with treatment they could avoid deadly or disabling liver disease or cancer. The estimated number of persons in California currently infected with untreated chronic viral hepatitis exceeds 700,000. Without improved screening and treatment efforts, from 2010 to 2030 the number of liver cancer cases in the U.S. is expected to rise 59 percent, with the highest increases expected among Hispanics and Asian American and Pacific Islanders. Over half of those with chronic HBV are Asian/Pacific Islanders, many of whom have emigrated from countries with high rates of hepatitis B infection. While smaller in number, the highest rate of infection is among African American men (2.3 per 100,000). African Americans and Hispanics have higher rates of hepatitis C infection than Whites. In addition, 34 percent of California’s prison population is infected with chronic HCV. Many aspects of the Affordable Care Act (ACA) provide opportunities to improve viral hepatitis prevention, screening, and treatment services. This is a crucial time for policymakers and advocates to ensure that ACA implementation efforts include strategies to reduce the current and future burden of viral hepatitis in California. This forum provided:
Confirmed Presenters:
Funding for the California Health Policy Forum is provided by grants from the
|



